Email this article 
Hide
Show all
Original Research
Red cell allo- and autoimmunisation in transfused sickle cell and cancer patients in Kenyatta National Hospital, Nairobi, Kenya
Submitted: 28 January 2015 | Published: 25 September 2015
About the author(s)
Caroline Mangare, Jomo Kenyatta University of Agriculture and Technology, Nairobi, KenyaAmos Mbugua, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
Peter Maturi, Kenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, Nairobi, Kenya
Jamila Rajab, Kenyatta National Hospital/ University of Nairobi, Department of Hematology and Blood Transfusion, Nairobi, Kenya
Rainer Blasczyk, Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
Hans-Gert Heuft, Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany
Abstract
Background: Currently, no data are available on the prevalence of red blood cell (RBC) antibody formation amongst Kenyan patients with multiple transfusion needs, such as patients with sickle cell disease (SCD) or haematological malignancies (HM) and solid (SM) malignancies.
Objectives: We determined the prevalence and specificities of RBC alloantibodies and autoantibodies in two patient groups with recurrent transfusion demands at Kenyatta National Hospital, Nairobi, Kenya.
Method: Between February and August 2014, 300 samples from SCD, HM and SM patients were collected and screened for alloantibodies. Samples from 51 healthy blood donors were screened for irregular antibodies and phenotyped.
Results: Amongst the 228 patients with viable samples (SCD, n = 137; HM, n = 48; SM, n = 43), the median transfusion frequency was two to three events per group, 38 (16.7%) were RBC immunised and 32 (14.0%) had a positive direct antiglobulin test. We identified specific alloantibodies in six patients (2.6%). Four of these six were SCD patients (2.9%) who had specific RBC alloantibodies (anti-Cw, anti-M, anti-Cob, anti-S); amongst HM patients one had anti-K and one had anti-Lea. RBC autoantibody prevalence was 3.1% (7/228). Amongst the healthy blood donors, the Ror, ccD.ee and R2r, ccD.Ee phenotypes accounted for 82% of the Rhesus phenotypes and all were Kell negative.
Conclusion: The numbers of transfusions and the rates of RBC alloantibodies are low and the most important RBC alloantibody-inducing blood group antigens are relatively homogeneously distributed in this population. A general change in the Kenyatta National Hospital pre-transfusion test regimen is thus not necessary. The current transfusion practice should be reconsidered if transfusion frequencies increase in the future.
Keywords
Metrics
Total abstract views: 5953Total article views: 9229
Crossref Citations
1. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease
Lilian A. Boateng, Andrew D. Campbell, Robertson D. Davenport, Alex Osei‐Akoto, Sheri Hugan, Akwasi Asamoah, Henk Schonewille
Transfusion vol: 59 issue: 6 first page: 2016 year: 2019
doi: 10.1111/trf.15197